| Title | Guidance: Assessing COVID-19-Related Symptoms in Outpatient Adult and Adolescent Subjects in Clinical Trials of Drugs and Biological Products for COVID-19 Prevention or Treatment |
| ToC Doc | Assessing COVID-19-Related Symptoms in Outpatient Adult and Adolescent Subjects in Clinical Trials of Drugs and Biological Products for COVID-19 Prevention or Treatment |
| Docket Number | 2024-03622 |
| Type | Notice |
| Subject | Guidance: Assessing COVID-19-Related Symptoms in Outpatient Adult and Adolescent Subjects in Clinical Trials of Drugs and Biological Products for COVID-19 Prevention or Treatment |
| Publication Date | 2024-02-22 |
| Last Updated Date | 2024-02-21 08:15:09 -0500 |
| Last Public Inspection | 2024-02-21 |
| Filed At | 2024-02-21T08:45:00.000-05:00 |
| 2024-03622_PI.pdf (110314 bytes) | |
| Download | TXT / HTML / JSON |
| Number of Pages | 7 |
| Filing Type | regular |
| Agencies | Food and Drug Administration |
You can find the raw source document below...